The DOI matches its Crossref record; 61 of the 64 references it cites were found in a registry or an index.
Global incidence and mortality of severe fungal disease
Open accessAbstract
Current estimates of fungal disease incidence and mortality are imprecise. Population at risk denominators were used to estimate annual incidence for 2019-21. Extensive literature searches from 2010 to 2023 were combined with over 85 papers on individual country and global disease burden. Crude and attributable mortality were estimated using a combination of untreated mortality, the proportion of patients who are treated, and percentage survival in treated patients. Awareness, guidelines, and accessibility of diagnostics and therapies informed the ratio of treated to untreated cases. Estimates do not include influenza or COVID-19 outbreaks. Data from more than 120 countries were included. Annually, over 2 113 000 people develop invasive aspergillosis in the context of chronic obstructive pulmonary disease, intensive care, lung cancer, or haematological malignancy, with a crude annual mortality of 1 801 000 (85·2%). The annual incidence of chronic pulmonary aspergillosis is 1 837 272, with 340 000 (18·5%) deaths. About 1 565 000 people have a Candida bloodstream infection or invasive candidiasis each year, with 995 000 deaths (63·6%). Pneumocystis pneumonia affects 505 000 people, with 214 000 deaths (42·4%). Cryptococcal meningitis affects 194 000 people, with 147 000 deaths (75·8%). Other major life-threatening fungal infections affect about 300 000 people, causing 161 000 deaths (53·7%). Fungal asthma affects approximately 11·5 million people and might contribute to 46 000…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, while there has been an overall reduction in incidence, new challenges have emerged including a shift to non-albicans Candida spp., and novel species such as C. auris, breakthrough infections, and drug resistance.2”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [2]
In the citing paper
“However, while there has been an overall reduction in incidence, new challenges have emerged including a shift to non-albicans Candida spp., and novel species such as C. auris, breakthrough infections, and drug resistance.2”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [2]
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Self-citationGlobal and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
Self-citationGlobal Burden of Disease 2019 Cancer Collaboration, Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., Henrikson, H. J., Lu, D., Pennini, A., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6987 · Cited by 2,026
Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,014
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861
Self-citationVentilator-associated pneumonia in adults: a narrative review
Papazian, L., Klompas, M., & Luyt, C.-E. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05980-0 · Cited by 1,010
Global Epidemiology of Mucormycosis
Prakash, H., & Chakrabarti, A. (2019) · Journal of Fungi · doi:10.3390/jof5010026 · Cited by 938
Momtazmanesh, S., Moghaddam, S. S., Ghamari, S.-H., Rad, E. M., Rezaei, N., Shobeiri, P., Aali, A., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., Abdelmasseh, M., et al. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.101936 · Cited by 810
Global burden of recurrent vulvovaginal candidiasis: a systematic review
Denning, D. W., Kneale, M., Sobel, J. D., & Rautemaa-Richardson, R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30103-8 · Cited by 639
Self-citationThe global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis
Rajasingham, R., Govender, N. P., Jordan, A., Loyse, A., Shroufi, A., Denning, D. W., Meya, D. B., Chiller, T. M., & Boulware, D. R. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00499-6 · Cited by 587
Self-citation
Research works printed but not linked: 1
- Ning, 2020, The global distribution, drivers, and burden of talaromycosis 1964–2018, Conference of Retrovirus and Opportunistic Infections
Cited by
Cornely, O. A., Sprute, R., Bassetti, M., Chen, S. C.-A., Groll, A. H., Kurzai, O., Lass-Flörl, C., Ostrosky-Zeichner, L., Rautemaa-Richardson, R., Revathi, G., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00749-7 · Cited by 410
The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation
Casalini, G., Giacomelli, A., & Antinori, S. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(24)00042-9 · Cited by 197
The pathobiology of human fungal infections
Brown, G. D., Ballou, E. R., Bates, S., Bignell, E., Borman, A. M., Brand, A., Brown, A. J. P., Coelho, C., Cook, P. C., Farrer, R. A., et al. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01062-w · Cited by 175
Hoenigl, M., Arastehfar, A. A., Arendrup, M. C., Brüggemann, R. J. M., Carvalho, A., Chiller, T. M., Chen, W., Egger, M., Feys, S., Gangneux, J., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-23 · Cited by 174
Fungal impacts on Earth’s ecosystems
Case, N. T., Gurr, S. J., Fisher, M. C., Blehert, D. S., Boone, C. M., Casadevall, A., Chowdhary, A., Cuomo, C. A., Currie, C. R., Denning, D. W., et al. (2025) · Nature · doi:10.1038/s41586-024-08419-4 · Cited by 137
Self-citation
Metadata
- Authors
- Denning, D. W.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Denning, David W
- ORCID
- Denning, David W
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2024-07
- Volume
- 24
- Issue
- 7
- Pages
- e428-e438
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W4390919957
- Cited by
- 1,640
- References
- 64
- Citations by year
- 2026: 681 · 2025: 666 · 2024: 292
- FWCI
- 136.24
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- SSRN Electronic Journal (acceptedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Canadian Institute for Advanced Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- invasive fungal infections, global burden of disease, incidence, mortality, invasive aspergillosis, chronic pulmonary aspergillosis, invasive candidiasis, candidemia, Pneumocystis carinii pneumonia, cryptococcal meningitis, fungal asthma, attributable mortality, vulnerable populations
- MeSH terms
- Humans, Mycoses, Global Health, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global incidence and mortality of severe fungal disease. https://app.cochat.ai/papers/10.1016/s1473-3099(23)00692-8
- The paper
- Denning, D. W. (2024). Global incidence and mortality of severe fungal disease. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(23)00692-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.